𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A placental type of membrane-bound arylamidase in serum and ascites from a patient with renal cell carcinoma

✍ Scribed by Hiwada Kunio; Kokubu Tatsuo; Tokioka-Terao Mamiko

Book ID
115822375
Publisher
Elsevier Science
Year
1978
Tongue
English
Weight
210 KB
Volume
88
Category
Article
ISSN
0009-8981

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Elevated levels of serum aldolase A in p
Elevated levels of serum aldolase A in patients with renal cell carcinoma
✍ Takashi, M. ;Zhu, Y. ;Nakano, Y. ;Miyake, K. ;Kato, K. πŸ“‚ Article πŸ“… 1992 πŸ› Springer 🌐 English βš– 371 KB

To clarify whether serum aldolase A is a useful biomarker for renal cell carcinoma (RCC), we determined serum levels of the aldolase A isozyme by an enzyme immunoassay in patients suffering from RCC, other urological tumors, and benign urological diseases. Forty-six of 126 patients with RCC (37%) ha

Identification and characterization of a
Identification and characterization of a Kunitz-type protease inhibitor in ascites fluid from patients with ovarian carcinoma
✍ Hiroshi Kobayashi; Yasuyuki Hirashima; Gun W. Sun; Hidekazu Ohi; Michio Fujie; T πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 French βš– 423 KB πŸ‘ 1 views

Urinary trypsin inhibitor (UTI; Mr 40 kDa) is a Kunitz-type protease inhibitor that efficiently inhibits cell-associated trypsin and plasmin activities. The aim of this study is to examine the expression pattern of UTI in the human ovarian carcinoma ascites fluid by Western blotting, zymography, imm